Related references
Note: Only part of the references are listed.Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
Li-Yang Hsu et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Recent updates of carbapenem antibiotics
Mohammed I. El-Gamal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Revival of old antibiotics: needs, the state of evidence and expectations
Hiba Zayyad et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Resistance to polymyxins in Gram-negative organisms
Katy Jeannot et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes
Keith S. Kaye et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
Latania K. Logan et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study
Jingjing Quan et al.
LANCET INFECTIOUS DISEASES (2017)
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study
Yang Wang et al.
LANCET INFECTIOUS DISEASES (2017)
High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance
Morgan A. Wambaugh et al.
PLOS BIOLOGY (2017)
Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes
Sheng-Kang Chiu et al.
PLOS ONE (2017)
Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States
Michael J. Satlin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
Laurent Poirel et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
Krystyna M. Kazmierczak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014
Laura F. Mataseje et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
National epidemiology of carbapenem-resistant and extensively drug- resistant Gram-negative bacteria isolated from blood samples in China in 2013
A. Xu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Agents of Last Resort Polymyxin Resistance
Keith S. Kaye et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance
Abiola Olumuyiwa Olaitan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Plasmid-mediated colistin resistance: the final blow to colistin?
Jean-Marc Rolain et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Emergence of polymyxin resistance in Gram-negative bacteria
Abiola Olumuyiwa Olaitan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Thien B. Tran et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?
Jason M. Pogue et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Dissemination of the mcr-1 colistin resistance gene
Yongfei Hu et al.
LANCET INFECTIOUS DISEASES (2016)
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Sylvie Garneau-Tsodikova et al.
MEDCHEMCOMM (2016)
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Johann D. D. Pitout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013)
Hello S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
Hosam M. Zowawi et al.
NATURE REVIEWS UROLOGY (2015)
Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore
Moi Lin Ling et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2015)
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
Haley J. Morrill et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Imaging the distribution of polymyxins in the kidney
Bo Yun et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management
Elizabeth Temkin et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS: INFECTIOUS DISEASES OF CURRENT AND EMERGING CONCERN (2014)
Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
Matthew E. Falagas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Variation in Potency and Spectrum of Tigecycline Activity against Bacterial Strains from US Medical Centers since Its Approval for Clinical Use (2006 to 2012)
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antibacterial Drug Development: Challenges, Recent Developments, and Future Considerations
S. Nambiar et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
An analysis of FDA-approved drugs for infectious disease: antibacterial agents
Michael S. Kinch et al.
DRUG DISCOVERY TODAY (2014)
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
Ilias Karaiskos et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
The role of tigecycline in the treatment of infections in light of the new black box warning
Deepali Dixit et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases
Anu Jain et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review
K. Brust et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge
P. Nordmann
MEDECINE ET MALADIES INFECTIEUSES (2014)
Drug Repurposing: Far Beyond New Targets for Old Drugs
T. I. Oprea et al.
AAPS JOURNAL (2012)
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Paritosh Prasad et al.
CLINICAL INFECTIOUS DISEASES (2012)
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient
C. Rodriguez-Avial et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Neil Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains
A. Doleans-Jordheim et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
Argyris S. Michalopoulos et al.
ANNALS OF INTENSIVE CARE (2011)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Sara E. Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2009)
The role of floxuridine in metastatic liver disease
Derek G. Power et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Meropenem - A review of its use in the treatment of serious bacterial infections
Claudine M. Baldwin et al.
DRUGS (2008)
Potential of old-generation antibiotics to address current need for new antibiotics
Matthew E. Falagas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
New antibiotic agents for bloodstream infections
Paschalis I. Vergidis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Aminoglycoside-induced ototoxicity
Erol Selimoglu
CURRENT PHARMACEUTICAL DESIGN (2007)
Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin
G. L. French
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Tigecycline: A new glycylcycline for treatment of serious infections
GA Noskin
CLINICAL INFECTIOUS DISEASES (2005)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
FDA drug approval summary:: Azacitidine (5-azacytidine, Vidaza™) for injectable suspension
E Kaminskas et al.
ONCOLOGIST (2005)
Evaluation of colistin as an agent against multi-resistant in Gram-negative bacteria
J Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects
G Muralidharan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Share Paper
